Hospital-onset clostridium difficile infection rates in persons with cancer or Hematopoietic stem cell transplant: A C3IC network report

Mini Kamboj, Crystal Son, Sherry Cantu, Roy F. Chemaly, Jeanne Dickman, Erik Dubberke, Lisa Engles, Theresa Lafferty, Gale Liddell, Mary Ellen Lesperance, Julie E. Mangino, Stacy Martin, Jennie Mayfield, Sapna A. Mehta, Susan O'Rourke, Cheryl S. Perego, Randy Taplitz, Janet Eagan, Kent A. Sepkowitz

Research output: Contribution to journalArticle

39 Scopus citations

Abstract

A multicenter survey of 11 cancer centers was performed to determine the rate of hospital-onset Clostridium difficile infection (HOCDI) and surveillance practices. Pooled rates of HO-CDI in patients with cancer were twice the rates reported for all US patients (15.8 vs 7.4 per 10,000 patient-days). Rates were elevated regardless of diagnostic test used.

Original languageEnglish
Pages (from-to)1162-1164
Number of pages3
JournalInfection Control and Hospital Epidemiology
Volume33
Issue number11
DOIs
StatePublished - Nov 2012

Fingerprint Dive into the research topics of 'Hospital-onset clostridium difficile infection rates in persons with cancer or Hematopoietic stem cell transplant: A C3IC network report'. Together they form a unique fingerprint.

Cite this